Literature DB >> 1887566

Immunological properties of Actinobacillus pleuropneumoniae hemolysin I.

J Frey1, J Nicolet.   

Abstract

The 105 kDa hemolysin I protein from Actinobacillus pleuropneumoniae serotype I type strain 4074 (HlyI) was shown by immunoblot analysis to be the predominant immunogenic protein if convalescent field sera or sera from pigs experimentally infected with A. pleuropneumoniae serotype 1 were used. SDS gel- and immunoblot-analysis using total culture, washed cells or culture supernatant showed that HlyI is essentially secreted and is not found attached to the bacteria. Proteins in the 105 kDa range that react strongly with anti-HlyI antibody, are produced by all serotypes and are presumed to be their hemolysins. Sera from pigs experimentally infected with each of the 12 serotypes strongly reacted with HlyI. In addition, some sera from pigs that were confirmed to be negative for A. pleuropneumoniae, also reacted with HlyI as well as with related proteins from Actinobacillus rossii and Actinobacillus suis. These two species produce proteins in the 105 kDa range which cross-react strongly with HlyI. They could be the source of the immunological reactions of the A. pleuropneumoniae-negative sera with HlyI. However, no cross-reactions could be found between HlyI and the Pasteurella haemolytica leukotoxin, the Escherichia coli alpha-hemolysin or related proteins from various hemolytic E. coli strains isolated from pigs. The immunological cross-reactions of HlyI with related proteins from A. rossii, A. suis and possibly from other bacterial species may create uncertainty in interpretation if HlyI is used as the antigen in serodiagnosis of A. pleuropneumoniae.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1887566     DOI: 10.1016/0378-1135(91)90099-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli.

Authors:  J Frey; H van den Bosch; R Segers; J Nicolet
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Transposon mutagenesis in Actinobacillus pleuropneumoniae with a Tn10 derivative.

Authors:  R I Tascon; E F Rodriguez-Ferri; C B Gutierrez-Martin; I Rodriguez-Barbosa; P Berche; J A Vazquez-Boland
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

4.  Partial characterization of Streptococcus suis type 2 hemolysin.

Authors:  I Feder; M M Chengappa; B Fenwick; M Rider; J Staats
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

5.  Nucleotide sequence of the hemolysin I gene from Actinobacillus pleuropneumoniae.

Authors:  J Frey; R Meier; D Gygi; J Nicolet
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

6.  Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae.

Authors:  Falk Fr Buettner; Sarah A Konze; Alexander Maas; Gerald F Gerlach
Journal:  Proteome Sci       Date:  2011-04-20       Impact factor: 2.480

7.  Generation of transgenic corn-derived Actinobacillus pleuropneumoniae ApxIIA fused with the cholera toxin B subunit as a vaccine candidate.

Authors:  Min-Kyoung Shin; Myung Hwan Jung; Won-Jung Lee; Pil Son Choi; Yong-Suk Jang; Han Sang Yoo
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

8.  Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines.

Authors:  Ian J Passmore; Anna Andrejeva; Brendan W Wren; Jon Cuccui
Journal:  BMC Vet Res       Date:  2019-01-03       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.